Melanoma vaccine

Known as: melanoma, melanoma vaccines, vaccine melanoma 
A cancer vaccine prepared from human melanoma cancer cells. It can be used alone or with other therapy in treating melanoma.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2015
Highly Cited
2015
PURPOSE Talimogene laherparepvec (T-VEC) is a herpes simplex virus type 1-derived oncolytic immunotherapy designed to selectively… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2013
Highly Cited
2013
PURPOSE Nivolumab, a human immunoglobulin G4-blocking antibody against the T-cell programmed death-1 checkpoint protein, has… (More)
Is this relevant?
Highly Cited
2008
Highly Cited
2008
We developed an in vitro method for isolating and expanding autologous CD4+ T-cell clones with specificity for the melanoma… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2008
Highly Cited
2008
Tumour-initiating cells capable of self-renewal and differentiation, which are responsible for tumour growth, have been… (More)
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
PURPOSE Phenotypic and functional features of myeloid suppressor cells (MSC), which are known to serve as critical regulators of… (More)
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Immunization to multiple defined tumor antigens for specific immune therapy of human cancer has thus far proven difficult… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Dendritic cells (DCs) are considered to be promising adjuvants for inducing immunity to cancer. We used mature, monocyte-derived… (More)
  • table I
  • table II
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
1998
Highly Cited
1998
The cloning of the genes encoding cancer antigens has opened new possibilities for the treatment of patients with cancer. In this… (More)
Is this relevant?
Highly Cited
1998
Highly Cited
1998
Melanoma is the main cause of death in patients with skin cancer1. Cytotoxic T lymphocytes (CTLs) attack melanoma cells in an HLA… (More)
Is this relevant?
Highly Cited
1990
Highly Cited
1990
BACKGROUND AND METHODS Treatment with tumor-infiltrating lymphocytes (TIL) plus interleukin-2 can mediate the regression of… (More)
Is this relevant?